Showing results (311-320 of 345) with videos related to

Sort By:
Pageof 35
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1990
IL-2-PE40 prevents the development of tumors in mice injected with IL-2 receptor expressing EL4 transfectant tumor cellsR W Kozak, H Lorberboum-Galski, L Jones, et al.
Oncogene|October 10, 2012
Prognostic value of the hDMP1-ARF-Hdm2-p53 pathway in breast cancerD Maglic, S Zhu, E A Fry, et al.
Carcinogenesis|September 29, 2001
p53-independent apoptosis mediated by tachpyridine, an anti-cancer iron chelatorR D Abeysinghe, B T Greene, R Haynes, et al.
Cancer Cell|October 16, 2007
Mutually exclusive inactivation of DMP1 and ARF/p53 in lung cancerAli Mallakin, Takayuki Sugiyama, Pankaj Taneja, et al.
The Journal of Pathology|December 25, 2014
DMP1β, a splice isoform of the tumour suppressor DMP1 locus, induces proliferation and progression of breast cancerDejan Maglic, Daniel B Stovall, J Mark Cline, et al.
BMC Cancer|April 2, 2010
Cancer resistance of SR/CR mice in the genetic knockout backgrounds of leukocyte effector mechanisms: determinations for functional requirementsAnne M Sanders, John R Stehle, Michael J Blanks, et al.
Cancer Research|March 1, 1987
Antitumor activity of an immunotoxin in a nude mouse model of human ovarian cancerD J FitzGerald, M J Bjorn, R J Ferris, et al.
Seminars in Pediatric Surgery|August 1, 1996
Molecular biology and the pediatric surgeon: definitions and basic methodologyE P Tagge, D U Tagge, J C Chandler, et al.
Cancer Cell International|August 5, 2011
Novel innate cancer killing activity in humansMichael J Blanks, John R Stehle, Wei Du, et al.
Protein Expression and Purification|December 28, 2007
GMP production and characterization of the bivalent anti-human T cell immunotoxin, A-dmDT390-bisFv(UCHT1) for phase I/II clinical trialsJung Hee Woo, Jen-Sing Liu, Soo Hyun Kang, et al.
Pageof 35